Skip to main content

Table 1 Baseline characteristics of Dutch and all included patients

From: Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry

 Netherlands (N = 1189)World (N = 52,014)
Female sex, n (%)504 (42.4)22,987 (44.2)
Age, mean (sd)70.7 (9.9)69.7 (11.5)
 < 65, n (%)311 (26.2)15,693 (30.2)
 65–74, n (%)426 (35.8)16,948 (32.6)
 ≥ 75, n (%)452 (38.0)19,373 (37.2)
BMI (kg/m2), mean (sd)28.5 (5.3)27.8 (5.7)
Congestive Heart Failure, n (%)82 (6.9)10,397 (20.0)
Hypertension, n (%)775 (65.5)39,585 (76.3)
Diabetes Mellitus, n (%)238 (20.0)11,540 (22.2)
Stroke/TIA, n (%)137 (11.5)5954 (11.4)
PE or DVT, n (%)22 (1.9)1356 (2.6)
Coronary artery disease, n (%)222 (18.7)11,232 (21.6)
Acute Coronary Syndrome, n (%)166 (14.0)4895 (9.5)
Chronic Kidney Disease, n (%)
 None377 (31.7)23,919 (46.0)
 Stages 1 to 2629 (52.9)16,508 (31.7)
 Stages 3 to 5118 (9.9)5373 (10.3)
History of Bleeding, n (%)25 (2.1)1317 (2.5)
Hypercholesterolemia, n (%)422 (36.0)20,940 (41.6)
CHA2DS2-VASc3.1 (1.5)3.2 (1.6)
HAS-BLED1.4 (0.9)1.4 (0.9)
Care Setting Speciality at Diagnosis, n (%)
 Cardiology1097 (92.3)34,165 (65.7)
 Other Hospital Departments30 (2.5)10,434 (20.1)
 Primary Care / General Practice62 (5.2)7410 (14.2)
  1. BMI Body mass index, VKA Vitamin K antagonist, NOAC Non-vitamin K antagonist oral anticoagulant, TIA Transient ischaemic attack, PE Pulmonary embolism, DVT Deep venous thrombosis